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Abstract : Objective : One major complication associated with STB is intratumoral hematoma, which is also the 
most common cause of morbidity related to permanent paralysis and mortality in STB. The risk of perioperative 
hemorrhage is generally between 1% and 10%, but this could be an underestimation since it is not common for 
many neurosurgeons to perform CT scans after uncomplicated STBs. In this study, we describe the incidence of 
cerebral hemorrhage, including asymptomatic cerebral hemorrhage. Methods : We recently reviewed data on the 
diagnosis rate and occurrence of complications, including symptomatic and asymptomatic cerebral hemorrhage, 
in 80 patients who underwent STB at our facility between 2005 and 2014. Results : Histological diagnosis was 
established for 75 cases (93.8%), glioma was the most frequently encountered tumor. Symptomatic hemorrhage 
was observed in two cases (2.6%), with the symptoms subsiding within two days. The morbidity and mortality 
rate was 0%. However, asymptomatic hemorrhages were observed in 23 cases (28.8%).  Conclusion : Stereotactic 
biopsy is a less invasive procedure for obtaining samples of brain tumors for diagnosis. The bleeding of the tis-
sue-resection cavity that includes asymptomatic hemorrhage occurs at a constant rate. It is important to reduce 
the symptomatic bleeding associated with stereotactic biopsy. J. Med. Invest. 66 : 314-318, August, 2019
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INTRODUCTION
 
Therapeutic strategies for intracranial mass lesions are most 
effective when based on histopathological diagnoses, rather 
than upon clinical and radiographic findings alone(4). When the 
lesions are strongly suspected to be malignant tumors, direct 
surgical resection should be considered, because massive tumor 
excision has a significant positive impact on prognosis and facil-
itates histopathological analysis (13). Sometimes, direct surgical 
resection is difficult because of multiple lesions, deep-seated 
cerebral lesions, and the patient’s age or general condition. How-
ever, obtaining tissue for analysis is critical for guide therapy 
and the prevention of unnecessary interventions. Presently, ste-
reotactically guided biopsy is commonly used to obtain samples 
for the histopathological diagnosis of tumors located in deep or 
eloquent areas within the brain. Stereotactic biopsy (STB) has 
reduced the morbidity associated with open cranial surgery and 
nonstereotactic techniques and has minimized disruption to 
normally functioning neural structures (1, 5). In fact, computed 
tomography (CT)/magnetic resonance imaging (MRI)-assisted 
STB is now routinely used for diagnosis and is considered an ac-
curate and relatively safe procedure. Such neuroimaging-based 
STB procedures are less invasive, especially for surgically inac-
cessible lesions and for patients who cannot undergo craniotomy 
because of their general condition (9, 11, 14, 17, 20). However, 
the risk of perioperative complications remains, with data from 
a large meta-analysis revealing a major morbidity rate of 3.5% 
and a mortality rate of 0.7% (6, 19). In some reports, complication 
rates have ranged from 6% to 12% and permanent morbidity 
and mortality from 0% to 6.4% (12). Brain edema, seizure, and 
infection have been reported, although the major complication 
associated with STB was intratumoral hematoma. The risk for 
perioperative hemorrhage was generally found to range from 
1% to 10% (1, 3, 5, 9, 14, 17, 21). However, these results may be 
an underestimation because it is uncommon for neurosurgeons 
to obtain routine CT scans after uncomplicated/asymptomatic 
STBs (2). In several studies, silent hemorrhage following un-
complicated STBs was reported to range from 8% to 53.9% (10). 
We have performed STBs using a Leksell system in patients 
with multifocal, deep-seated cerebral lesions, as well as in elderly 
patients or patients whose conditions had deteriorated. During 
these STBs, we inserted a drainage tube into the site of tissue 
resection after the tissue sample was removed. We use this pro-
tocol to prevent morbidity and mortality due to cerebral hemor-
rhage as a complication by the astriction of extraction cavity and 
the draining of the bleeding and to enable the identification of 
the resected site using postoperative CT scan. Upon completion 
of the biopsy, a CT scan is performed in all cases, regardless of 
the symptomatic status, to check for complications such as hem-
orrhages and to confirm the accuracy in targeting the resection 
site. We recently reviewed data on the diagnosis rate and com-
plications, specifically symptomatic and asymptomatic (silent) 
cerebral hemorrhage, in 80 patients who underwent STB with 
the Leksell system at our facility between 2005 and 2014. In this 
study, we describe the complications and diagnostic benefits of 
neuroimaging-guided STB. 
CLINICAL MATERIAL AND METHODS
A retrospective study was conducted with institutional review 
board approval from University of Tokushima. Patients were 
admitted to the Division of Neurosurgery at the Tokushima Uni-
versity hospital between November 2005 and December 2014. 
Data from 80 patients (44 men and 36 women) with a mean age 
of 63.3 years (range : 14–86 years), who underwent stereotactic 
biopsy using a Leksell apparatus and prospective CT scanning 
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within hours of their procedure, were analyzed. Their lesions 
were either multifocal, diffuse, or seated in deep intrinsic cere-
bral areas, and were considered inaccessible for direct removal. 
Routine blood tests, including platelet count, prothrombin time 
(PT), and active partial thrombin time (APTT) were performed 
for all patients. The following medical conditions were included 
for statistical analysis : hypertension, history of diabetes, recent 
aspirin use, and procedures performed under local or general 
anesthesia.
STEREOTACTIC BIOPSY TECHNIQUE
All biopsies were performed at our institution by three neuro-
surgeons who were specialized and experienced in performing 
stereotactic techniques and were certified by the Japan Neuro-
surgical Society. A Leksell model G stereotactic frame system 
(AB Elekta Instruments, Stockholm, Sweden) was used, with 
MRI guidance for stereotactic lesion localization. After place-
ment of the head-frame, all patients underwent MRI with a 
slice thickness of 1 mm. For biopsy, we usually select one site on 
a contrast-enhanced lesion, or a lesion with hyperintensity on 
T2-weighted MR images or fluid attenuated inversion recovery 
(FLAIR). The patient was put under local or general anesthesia 
and a burr hole was drilled. The dura was incised in a cruciate 
fashion, and whenever possible, biopsy trajectories were de-
signed to avoid entrance through a sulcus, cortical artery, venous 
structure, or ventricle. The pia-arachnoid was coagulated with 
bipolar forceps, and then an incision was made with a small scal-
pel. A Sedan type, side-cutting aspiration biopsy needle (outer 
diameter 2.5 mm) was inserted at the target site, and four tissue 
samples were obtained from four different directions. After ob-
taining the tissue samples, portions of the resected tissue were 
submitted to a pathologist for rapid examination. After the tissue 
was histologically identified, a silicon drain tube with an outer 
diameter of 2.5 mm was inserted into the resection cavity with 
a Kirschner stainless steel wire (inner sheath) and connected 
to the drainage circuit to stop bleeding through the astriction of 
the extraction cavity and the draining of the blood (Figure 1 left).
All patients underwent postoperative CT scanning immedi-
ately to confirm that the sample was from the target site, and 
to identify complications such as intracranial bleeding (Figure 
1 right). New hemorrhages were classified by size (maximum 
intraparenchymal diameter) (Figure 2). The following day, all 
patients underwent CT scanning and the drainage tubes were 
removed without cerebral hemorrhage. 
Statistical analysis
In each case, medical charts and laboratory results were 
reviewed to identify factors that may have increased the risk of 
post-biopsy intracranial hemorrhage associated with the pro-
cedure. Fisher’s exact probability test was used to evaluate the 
relationship between hemorrhagic complications and potential 
risk factors in a univariate model, using P = 0.05 as the thresh-
old of statistical significance. Odds ratios were calculated to 
estimate the magnitude of risk associated with each significant 
categorical variable. Factors evaluated included age and sex of 
patients, platelet count, history of hypertension, diabetes, use of 
anticoagulant or antiplatelet medications, location of lesion, par-
tial thromboplastin time, historical diagnosis, and procedures 
under local or general anesthesia. All analyses were conducted 
using EZR (Saitama Medical Center, Jichi Medical University, 
Saitama, Japan) (7). 
Figure 1.　Drainage tube insertion protocols and sample images.
A silicon drainage tube with an outer diameter of 2.5 mm was in-
serted using a Kirschner stainless steel wire (inner sheath) into the 
resection cavity (left). Postoperative computed tomography (CT) can be 
used to confirm whether the sample was from the target site (right).
Figure 2.　Representative images of stereotactic biopsy-related hemorrhages.
Representative computed tomography (CT) images of hemorrhages > 5 mm in size (left panel), hemorrhages < 5 mm (middle panel), 
and no hemorrhages (right panel).
5mm < 5mm > No hemorrhage
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RESULTS
Patient population
We analyzed data from 80 patients and their clinical data 
are summarized in Table 1. The age of patients ranged from 14 
to 86 years, with a mean age of 63.3 years at biopsy. Forty-four 
patients (55.0%) were male and 36 patients were female. The 
mean platelet count was 25.5 (10.9–72.9) × 104 /µl and the mean 
prothrombin time was 11.5 (9.1–31.4) seconds. Pre-existing med-
ical conditions were identified in 35 patients (43.8%), including 
a history of hypertension (n = 25) and diabetes (n = 10). In six 
patients, antiplatelet agents had already been administered 48 
hours before surgery. Twenty-one patients (26.3%) underwent 
biopsy under local anesthesia.
Target lesion
The stereotactically biopsied sites are summarized in Table 2. 
Forty cases (50.0%) involved tumors that were localized in the 
cerebral hemispheres : 20 cases (25%) involved tumors in the 
frontal lobe, 7 cases (8.8%) involved tumors in the temporal lobe, 
7 cases (8.8%) involved tumors in the parietal lobe, and 6 cases 
(7.5%) involved tumors in the occipital lobe. For forty patients 
(50.0 %), the lesions were located deep in the brain. Lesions were 




Histological diagnosis was established for 75 cases (93.8%) 
following STB. Of the 67 neoplasm cases, 65 were diagnosed 
as primary brain tumors. Histologically, glioma was encoun-
tered frequently (35 patients ; 43.8%), with 24 tumors (30%) 
determined to be glioblastoma, six (7.5%) determined to be low-
grade glioma, and five (6.3%) diagnosed as anaplastic glioma. 
Thirty tumors (37.5%) were malignant lymphomas and two 
(2.5%) were metastatic brain tumors (Table 3).
 
COMPLICATIONS AND INCIDENCE OF HEMORRHAGE ON 
ROUTINE POSTOPERATIVE CT SCAN
In the present study, no death was attributable to the stereo-
tactic procedure. The only two minor complications associated 
with STB were transient motor weakness caused by hemorrhage 
in the tissue-resection cavity and low level of consciousness 
caused by postoperative hemorrhage (2.6%). In the case involv-
ing the low level of consciousness, hydrocephalus, caused by in-
traventricular hemorrhage, occurred. However, these symptoms 
were temporary and completely disappeared within 48 hours. 
The total operative mortality and morbidity rate was 0% upon 
discharge (Table 4).
In the 25 patients (31.3%) in whom hemorrhage was detected 
on routine postoperative CT scan, intraparenchymal hemor-
rhages were smaller than 5 mm in diameter in 22 patients 
(27.5%) and larger than 5 mm in three patients (3.8%). In the 23 
patients, there were no hemorrhage-related neurological deficits 
(i.e., all hemorrhages that occurred were silent hemorrhages) 
(Table 5). 
Table 1.　Prebiopsy characteristics of 80 patients undergoing stereo-
tactic brain biopsy
Characteristic mean (range)
Age (yrs) 63.3 (14-86)
Sex (% male) 55.0%
Platelet count 25.5 (10.9-72.9)X104/µl
Prothrombin time (secs) 11.5 (9.1-31.4)
History of hypertension 31.3%
History of diabetes 12.5%
Recent aspirin use 7.5%
Local anesthesia 26.3%
N=80
Table 2.　Sites of stereotactic biopsies
Location No. of cases (%)
Frontal lobe 20 (25.0)
Temporal lobe 7 (8.8)
Parietal lobe 7 (8.8)
Occipital lobe 6 (7.5)
Cerebellum 2 (2.5)
Basal ganglia 30 (37.5)
Brain stem 1 (1.3)
Corpus callosum 7 (8.8)
N=80
Table 3.　Histological diagnosis
Lesion Type No. of Patients (%)
Low-grade astrocytoma 6 (7.5)
Anaplastic astrocytoma 5 (6.3)
Glioblastoma multiforme 24 (30.0)
Metastasis 2 (2.5)






Table 4.　Complications directly induced by stereotactic brain biopsy
Minor/Transient Permanent




consciousness 1 (1.3%) 0
Total 2 (2.6%) 0
Table 5.　Incidence of hemorrhage on routine postoperative comput-
ed tomography scans in 80 patients who underwent stereotactic brain 
biopsy
No. of Patients (%)
All Hemorrhages Asymptomatic hemorrages
< 5 mm 22 (27.5) 22 (27.5)
> 5 mm 3 (3.8) 1 (1.3)
total 25 (31.3) 23 (28.8)
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RISK FACTORS INFLUENCING HEMORRHAGE
The results following univariate analysis of the risk of post-bi-
opsy hemorrhage revealed a significant correlation with the 
degree to which the prothrombin time was longer than 12.7 
seconds (P = 0.014). These patients had a 7.43-fold risk of cere-
bral hemorrhage including asymptomatic hemorrhage compared 
to those with a normal prothrombin time. On the other hand, 
patients with malignant glioma had a 0.37-fold reduced risk of 
hemorrhage (P = 0.049). Variables which were not significantly 
correlated with risk include age and sex of patients, platelet 
count (< 150000), history of hypertension, history of diabetes, 
use of anticoagulant or antiplatelet medications, location of 
lesion, patients with malignant lymphoma, and procedures per-
formed under local anesthesia or general anesthesia (Table 6).
 
DISCUSSION
As specified above, we analyzed data from 80 patients who 
underwent STBs using the Leksell system, with insertion of a 
drainage tube according to our standard protocol. Many of these 
patients were at an advanced age, and the resected tissues were 
histologically diagnosed as lymphoma in many cases (37.5%). In 
a study by Franzini et al., 100 out of 940 patients had multiple 
lesions, which comprised malignant gliomas (37%), primary lym-
phomas (15%), brain metastases (15%), and low-grade gliomas 
(12%) (3). The prevalence of malignant lymphomas in our study 
is higher than that in the study by Franzini et al., possibly be-
cause our patient population comprised patients with multiple or 
deep lesions, systemic conditions and therefore cannot undergo 
tumor resection by open craniotomy, and advanced age. 
The pathological diagnosis rate using tissue samples acquired 
using the Leksell system in our institute is 93.8%, which is com-
parable to the values reported in the literature. However, with 
brain tumor biopsy, only part of the entire tumor can be collect-
ed. Particularly, in cases involving heterogeneous tumors such 
as gliomas, the site of resection does not always represent the 
tumoral region of high malignancy (15). To improve the precision 
of resection and sampling, and thus the diagnostic accuracy, it 
may be useful to identify an area with relatively high malignan-
cy by performing 11 C-methionine positron emission tomography 
(met-PET) or thallium scintigraphy. With the precision provided 
by the Leksell system, it is quite possible to target the high-den-
sity areas visualized using met-PET or thallium scintigraphy. 
Alternatively, diagnostic accuracy could be improved by setting 
multiple targets or collecting multiple tissue specimens, though 
this is viewed negatively by many investigators because of its 
increased risk of biopsy-related hemorrhage. At our facility, we 
select a single target and collect four tissue samples from the 
targeted area. 
The incidence of complications has been reported to range 
from 6% to 12% after STB, consisting mostly of reports of 
intracranial symptomatic hemorrhage. Malone et al. reported 
that patients with intracranial hemorrhage were significantly 
more likely to die in the hospital or experience a non-routine 
discharge. These patients have an in-hospital mortality rate 
that is six-fold higher than that for patients without hemorrhage 
(12). In this study, the mortality and morbidity rate, including 
infection and postoperative convulsions, was 0% excluding two 
cases (2.6%), but the symptoms subsided within two days. In 
the literature, the risk of perioperative hemorrhage ranges from 
1% to 10% (1, 3, 5, 9, 14, 17, 21). However, these results do not 
include asymptomatic hemorrhage. Asymptomatic hemorrhage 
was observed in 23 cases (28.8 %) at our facility. The incidence 
of asymptomatic hemorrhage has been reported in other studies 
to range from 8% to 53.9% (10, 15, 2). There is no generally 
accepted standard for postoperative management, monitoring, 
and surveillance of patients. Postoperative CT scans are not 
performed at many facilities if no symptoms are observed after 
biopsy. The studies reported in the literature include studies in 
which a CT scan was performed only in cases where symptoms 
were observed after biopsy. Thus, the incidence of hemorrhage 
reported in the literature is effectively that of symptomatic hem-
orrhage only, whereas the true incidence of hemorrhage (includ-
ing asymptomatic hemorrhage) after biopsy may be higher than 
previously reported due to cases of asymptomatic hemorrhage. 
The present study revealed a correlation between postoper-
ative hemorrhage (including asymptomatic hemorrhage) and 
prothrombin time. It is therefore advisable to consider this rela-
tionship when biopsy is performed. On the other hand, patients 
with malignant glioma in our study were at a modestly reduced 
risk for hemorrhage. This is in accordance with the results of 
Malone et al. (12). However, several authors have reported that 
gliomas of the basal ganglia and thalamus are risk factors for 
morbidity in a frame-based stereotactic biopsy (8, 14, 16, 18). 
Therefore, such an intervention should be performed in glioma 
patients only following careful preparation and consideration of 
the target site. Our study suggests that the surgical risk is not 
greater for lesions that are located in deep brain areas, although 
this is contrary to the reports of other studies (1, 5, 14, 19). 
In order to perform safe biopsies, it is important to avoid 
symptomatic hemorrhage. Therefore, careful planning should be 
enforced. In the literature, Nishihara et al. emphasized the im-
portance of the selected trajectory for the biopsy. They suggested 
that biopsies should be performed in such a way as to avoid the 
sulci and associated blood vessels, as well as the pyramidal tract, 
if it is near the target. 
CONCLUSION
Neurosurgeons can be presented with serious problems in 
cases of multiple cerebral lesions, advanced age, or deep-seated 
lesions. Intracranial hemorrhage is the most common cause of 
morbidity related to permanent paralysis and mortality in ste-
reotactic biopsy. However, intracranial symptomatic hemorrhage 
caused by STBs are rare. Stereotactic biopsy is a less invasive 
Table 6.　Risk factors that influence hemorrhage
Risk Factor Hemorrhage Gr No hemorrhage Gr ODDs Ratio P-Value
Age (70 <) 11/32 21/32 1.15 0.811
Gender (male) 16/44 28/44 1.48 0.477
PLT (< 150) 2/5 3/5 0.72 1.0
Hypertension 5/25 20/25 0.41 0.129
Diabetes 3/10 7/10 0.877 1.0
Antiplatelet 
agents 4/7 3/7 3.04 0.206
Deep-seated 
lesion 14/38 24/38 0.69 0.48
PT > 12.7s 6/8 2/8 7.43 0.014
Malignant 
glioma 14/30 16/30 0.37 0.049
Malignant 
lymphoma 7/30 23/30 2.00 0.221
Local
Anesthesia 5/21 16/21 0.57 0.42
Abbreviations : PLT, platelet count ; PT, prothrombin time
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procedure compared to open craniotomy. However, it can still be 
used to obtain the samples of brain tumors needed for diagnosis. 
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